To date, research suggests that the reuptake inhibition of monoamines, MAO inhibition, NMDA antagonism, and improved brain-derived neurotrophic factor signaling may be mechanistic factors responsible for the treatment of depression from saffron [99]. This evidence concerns the gene BDNF and depressive symptom measurement.